TABLE 2.
Joinpoint regression analysis of reproductive-related cancer incidence and mortality trends in women in Guangzhou 2010–2020.
| Cancers | Rate | AAPC (%,95%CI) | Trend 1 | Trend 2 | ||
|---|---|---|---|---|---|---|
| Period | APC (%,95%CI) | Period | APC (%,95%CI) | |||
| Breast cancer | ASIR | −0.4 (−2.0∼1.3) | 2010–2020 | −0.4 (−2.0∼1.3) | ||
| ASMR | 1.9 (−0.6∼4.4) | 2010–2016 | 5.0*(1.5∼8.7) | 2016–2020 | −2.6 (−7.9∼2.9) | |
| Cervical cancer | ASIR | −4.3*(−8.1∼−0.3) | 2010–2017 | 0.4 (−3.3∼4.1) | 2017–2020 | −14.3*(−25.9∼−0.8) |
| ASMR | 3.1 (−0.7–7.1) | 2010–2017 | 8.8*(4.6–13.3) | 2017–2020 | −9.1 (−20.0∼3.4) | |
| Uterine cancer | ASIR | 0.6 (−1.2–2.3) | 2010–2014 | 4.9*(0.4∼9.5) | 2014–2020 | −2.2*(−4.3∼−0.2) |
| ASMR | 0.7 (−2.1–3.4) | 2010–2020 | 0.7 (−2.1∼3.4) | |||
| Ovarian cancer | ASIR | −3.2*(−5.6∼−0.8) | 2010–2020 | −3.2*(−5.6∼−0.8) | ||
| ASMR | 1.9 (−0.4–4.3) | 2010–2020 | 1.9 (−0.4∼4.3) | |||
* means that it is statistically significant, p < 0.05, APC or AAPC was significantly different from 0 (two-sided p < 0.05).